Copyright
©The Author(s) 2025.
World J Diabetes. Feb 15, 2025; 16(2): 98085
Published online Feb 15, 2025. doi: 10.4239/wjd.v16.i2.98085
Published online Feb 15, 2025. doi: 10.4239/wjd.v16.i2.98085
Variable | Total | Obesity | Overweight | Normal weight | |||
n = 1967 | Diabetes, n = 162 | Non-diabetes, n = 370 | Diabetes, n = 184 | Non-diabetes, n = 683 | Diabetes, n = 81 | Non-diabetes, n = 487 | |
Age (years) | 59.4 ± 6.7 | 59.5 ± 6.1 | 58.8 ± 6.2 | 59.8 ± 6.9 | 59.2 ± 6.8 | 61.1 ± 6.8 | 59.8 ± 7.20 |
Men (%) | 49.1 | 35.8 | 37.3 | 53.8 | 50.7 | 54.3 | 57.7 |
Annual household income (%) | |||||||
< ¥50000 | 60.3 | 53.7 | 57.0 | 48.9 | 60.8 | 65.4 | 67.8 |
¥50000-99000 | 30.1 | 32.1 | 33.6 | 36.9 | 30.0 | 22.2 | 25.9 |
≥ ¥100000 | 9.5 | 14.2 | 9.5 | 14.2 | 9.2 | 12.4 | 6.4 |
Education (%) | |||||||
Elementary school or lower | 33.6 | 39.5 | 33.2 | 29.3 | 29.9 | 45.7 | 36.8 |
Middle school | 60.0 | 51.9 | 60.9 | 59.7 | 62.4 | 54.3 | 59.8 |
College or higher | 6.4 | 8.7 | 5.7 | 10.8 | 7.7 | 0 | 3.5 |
BMI (kg/m2) | 26.09 ± 3.47 | 30.53 ± 2.25 | 30.40 ± 2.22 | 25.97 ± 1.15 | 26.01 ± 1.14 | 22.35 ± 1.21 | 22.12 ± 1.34 |
WC (cm) | 88.0 ± 9.6 | 99.0 ± 6.9 | 97.6 ± 6.9a | 89.8 ± 6.1 | 87.5 ± 5.9b | 80.5 ± 5.5 | 80.0 ± 5.7 |
HC (cm) | 98.4 ± 6.9 | 104.9 ± 5.9 | 105.2 ± 6.2 | 97.3 ± 4.7 | 98.3 ± 4.7b | 92.3 ± 5.04 | 92.7 ± 4.7 |
WHR | 0.89 ± 0.07 | 0.94 ± 0.06 | 0.93 ± 0.06a | 0.92 ± 0.06 | 0.89 ± 0.06b | 0.87 ± 0.06 | 0.84 ± 0.06b |
ALT (U/L) | 22.5 ± 12.2 | 28.8 ± 20.6 | 23.9 ± 10.8b | 24.1 ± 16.7 | 22.2 ± 11.0a | 19.3 ± 8.9 | 19.6 ± 7.8 |
AST (U/L) | 23.3 ± 8.9 | 28.5 ± 14.4 | 23.5 ± 8.7 | 23.2 ± 13.8 | 23.0 ± 7.2a | 21.1 ± 8.0 | 23.2 ± 6.0b |
Cr (μmol/L) | 63.4 ± 33.6 | 61.6 ± 17.3 | 62.0 ± 14.2 | 68.4 ± 56.9 | 62.1 ± 14.5 | 76.6 ± 103.7 | 62.8 ± 31.5 |
FPG (mmol/L) | 6.38 ± 1.81 | 8.59 ± 2.28 | 5.80 ± 0.54b | 8.44 ± 2.23 | 5.76 ± 0.58b | 9.54 ± 3.81 | 5.64 ± 0.55b |
FINS (uIU/mL) | 9.25 ± 6.88 | 15.55 ± 10.09 | 12.02 ± 6.19b | 11.19 ± 10.16 | 8.57 ± 4.11b | 7.42 ± 11.53 | 5.60 ± 3.00 |
HbA1c (%) | 6.03 ± 1.04 | 7.31 ± 1.36 | 5.80 ± 0.47 | 7.12 ± 1.34 | 5.69 ± 0.40b | 7.30 ± 1.80 | 5.62 ± 0.70b |
HOMA-IR | 2.74 ± 2.69 | 6.07 ± 4.63 | 3.14 ± 1.82b | 4.22 ± 4.10 | 2.22 ± 1.16b | 3.04 ± 4.94 | 1.42 ± 1.84b |
SBP (mmHg) | 133 ± 18 | 137 ± 17 | 136 ± 18 | 137 ± 19 | 132 ± 16 | 136 ± 21 | 130 ± 18 |
DBP (mmHg) | 79 ± 11 | 81 ± 11 | 82 ± 12 | 79 ± 10 | 79 ± 10 | 75 ± 11 | 76 ± 11a |
Cholesterol (mmol/L) | 5.09 ± 1.41 | 5.27 ± 1.31 | 5.15 ± 1.09 | 5.15 ± 1.12 | 5.03 ± 0.94 | 5.14 ± 1.21 | 5.04 ± 0.92 |
Triglyceride (mmol/L) | 1.59 ± 1.41 | 2.26 ± 1.49 | 1.87 ± 1.51b | 2.00 ± 2.01 | 1.51 ± 1.13b | 1.41 ± 1.24 | 1.13 ± 1.21a |
LDL-C (mmol/L) | 2.98 ± 0.84 | 3.06 ± 0.91 | 3.07 ± 0.91 | 2.97 ± 0.93 | 2.99 ± 0.78 | 2.89 ± 0.93 | 2.91 ± 0.77 |
HDL-C (mmol/L) | 1.18 ± 0.31 | 1.06 ± 0.18 | 1.09 ± 0.24 | 1.11 ± 0.29 | 1.17 ± 0.27b | 1.30 ± 0.44 | 1.33 ± 0.36 |
vBMD | 103.0 ± 30.8 | 105.9 ± 33.2 | 102.1 ± 29.4 | 104.0 ± 32.9 | 103.9 ± 30.6 | 101.6 ± 30.4 | 100.8 ± 30.9 |
Diabetes | Non-diabetes | Total | ||||
β (95%CI) | P value | β (95%CI) | P value | β (95%CI) | P value | |
vBMD | ||||||
Model 1 | ||||||
One line effect | 0.54 (-0.20, 1.29) | 0.155 | 0.40 (0.01, 0.78) | 0.043 | 0.43 (0.09, 0.77) | 0.014 |
Model 2 | ||||||
BMI turning point (K), kg/m2 | 29.24 | 21.48 | 21.42 | |||
< K, effect 1 | 0.28 (-0.81, 1.38) | 0.612 | 3.84 (0.41, 7.26) | 0.028 | 3.70 (0.33, 7.08) | 0.032 |
> K, effect 2 | 1.12 (-0.83, 3.06) | 0.261 | 0.21 (-0.22, 0.64) | 0.339 | 0.28 (-0.09, 0.66) | 0.139 |
Effect 2 - 1 | 0.83 (-1.77, 3.43) | 0.532 | -3.63 (-7.22, -0.04) | 0.048 | -3.42 (-6.93, 0.09) | 0.056 |
LRT test | 0.529 | 0.047 | 0.056 | |||
Men | ||||||
Model 1 | ||||||
One line effect | 0.33 (-0.86, 1.52) | 0.589 | 0.53 (-0.08, 1.15) | 0.043 | 0.49 (-0.06, 1.04) | 0.080 |
Model 2 | ||||||
BMI turning point (K), kg/m2 | 26.45 | 22.33 | 21.65 | |||
< K, effect 1 | 1.07 (-1.26, 3.39) | 0.370 | 3.51 (0.56, 6.46) | 0.020 | 3.93 (0.14, 7.72) | 0.042 |
> K, effect 2 | -0.33 (-2.48, 1.82) | 0.763 | 0.05 (-0.73, 0.82) | 0.907 | 0.19 (-0.45, 0.83) | 0.567 |
Effect 2 - 1 | -1.40 (-5.18, 2.38) | 0.470 | -3.46 (-6.82, -0.11) | 0.043 | -3.74 (-7.82, 0.34) | 0.072 |
LRT test | 0.465 | 0.043 | 0.072 | |||
Women | ||||||
Model 1 | ||||||
One line effect | 0.7 (-0.2, 1.7) | 0.133 | 0.4 (-0.1, 0.8) | 0.143 | 0.49 (-0.06, 1.04) | 0.080 |
Model 2 | ||||||
BMI turning point (K), kg/m2 | 27.3 | 28.7 | 29 | |||
< K, effect 1 | -0.2 (-2.4, 2.0) | 0.844 | -0.1 (-0.8, 0.6) | 0.760 | -0.1 (-0.7, 0.6) | 0.879 |
> K, effect 2 | 1.4 (-0.3, 3.1) | 0.108 | 1.3 (0.1, 2.5) | 0.035 | 1.4 (0.4, 2.5) | 0.009 |
Effect 2 - 1 | 1.6 (-1.8, 5.0) | 0.347 | 1.4 (-0.2, 3.0) | 0.096 | 1.5 (0, 3.0) | 0.049 |
LRT test | 0.342 | 0.095 | 0.049 |
- Citation: Lv F, Cai XL, Zhang XY, Zhou XH, Han XY, Li YF, Ji LN. Association between body mass index and lumbar spine volumetric bone mineral density in diabetic and non-diabetic patients. World J Diabetes 2025; 16(2): 98085
- URL: https://www.wjgnet.com/1948-9358/full/v16/i2/98085.htm
- DOI: https://dx.doi.org/10.4239/wjd.v16.i2.98085